B27.91 Infectious mononucleosis, unspecified with polyneuropathy

Name of the Condition

• Infectious mononucleosis, unspecified with polyneuropathy

Summary

Infectious mononucleosis is a viral infection commonly caused by the Epstein-Barr virus (EBV). This variation involves polyneuropathy, a condition affecting peripheral nerves, which may complicate the clinical presentation. Symptoms typically include fever, sore throat, and swollen lymph nodes, with additional neurological manifestations due to the polyneuropathy. The condition primarily affects adolescents and young adults but can occur in other age groups. Management focuses on addressing both the viral infection and neurological symptoms.

Causes

Infectious mononucleosis is most often caused by the Epstein-Barr virus (EBV), a member of the herpesvirus family. The virus spreads through saliva, which can occur through kissing, sharing utensils or beverages, or other close contact. Polyneuropathy in this context may arise as a rare complication of the viral infection, potentially due to immune-mediated nerve inflammation or direct viral effects on peripheral nerves.

Risk Factors

• Adolescents and young adults, particularly those in close-contact environments like college dormitories.
• Exposure to EBV, especially in settings with frequent interpersonal contact.
• Weakened immune system due to conditions like HIV/AIDS or immunosuppressive therapy.
• Pre-existing neurological conditions that may increase susceptibility to nerve involvement.

Symptoms

• Persistent fatigue
• Fever
• Sore throat, often severe
• Swollen lymph nodes in the neck and armpits
• Neurological symptoms such as numbness, tingling, or weakness in the limbs (due to polyneuropathy)
• Enlarged spleen or liver (in some cases)
• Rash (less common)

Diagnosis

Diagnosis typically involves a combination of clinical evaluation and laboratory testing. A physical exam may reveal swollen lymph nodes or signs of nerve involvement. Blood tests, such as the Monospot test or EBV antibody test, confirm the viral infection. Nerve conduction studies or electromyography (EMG) may be used to assess polyneuropathy. Additional tests, like MRI or lumbar puncture, might be considered to rule out other neurological conditions.

Treatment Options

Treatment focuses on managing symptoms and addressing the underlying infection. Supportive care includes rest, hydration, and over-the-counter pain relievers for fever and sore throat. For polyneuropathy, medications such as corticosteroids or immunosuppressants may be used to reduce inflammation. In severe cases, physical therapy can help with mobility and nerve recovery. Antiviral therapies are generally not effective for EBV but may be considered in specific situations.

Prognosis and Follow-Up

Most individuals recover fully with appropriate care, though recovery from polyneuropathy may take longer and vary by severity. Follow-up appointments monitor neurological symptoms and overall recovery. Regular check-ups ensure complications, such as splenic rupture or persistent nerve damage, are addressed promptly. Most patients return to normal activities within weeks to months, depending on the extent of nerve involvement.

Complications

• Severe polyneuropathy leading to prolonged weakness or disability
• Splenic rupture (rare but serious)
• Liver inflammation (hepatitis)
• Neurological complications, such as Guillain-Barré syndrome (rare)
• Recurrent or chronic fatigue

Lifestyle & Prevention

• Avoid sharing utensils, drinks, or personal items to reduce EBV transmission.
• Practice good hygiene, including frequent handwashing.
• Get adequate rest to support immune function and recovery.
• Avoid contact sports or strenuous activities if the spleen is enlarged to prevent rupture.
• Manage stress and maintain a balanced diet to support overall health.

When to Seek Professional Help

Seek medical attention if you experience:

• Severe or worsening neurological symptoms, such as sudden weakness or numbness.
• High fever that does not improve with treatment.
• Difficulty breathing or swallowing.
• Abdominal pain (possible spleen enlargement or rupture).
• Persistent symptoms lasting more than two weeks.

Tips for Medical Coders

When coding B27.91, ensure the polyneuropathy is documented as a complication of infectious mononucleosis. Verify that the polyneuropathy is not the primary diagnosis, as the code specifies it as a secondary condition. Document the clinical relationship between the viral infection and neurological symptoms to support accurate coding. Review the patient’s medical record for confirmation of both the infectious mononucleosis and the polyneuropathy to meet coding guidelines.